Genmab A/S (GNMSF) Return on Sales (2018 - 2026)
Genmab A's (GNMSF) quarterly Return on Sales came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and down 127.41% on a QoQ basis from 0.0% in Q3 2025.
Genmab A/S (GNMSF) Return on Sales (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 6 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales retreated to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 0.0% in Q1 2026.
- A 3-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
- The widest YoY moves for Return on Sales: up 0 bps in 2025, down 0 bps in 2025.
- Tracing GNMSF's Return on Sales over 3 years: stood at 0.0% in 2024, then rose by 17 bps to 0.0% in 2025, then tumbled by 127 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 6,724,845,265.25% |
| Dec 31, 2018 | 0.00% |